BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 11146724)

  • 1. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.
    Kempen JH; Jabs DA; Dunn JP; West SK; Tonascia J
    Arch Ophthalmol; 2001 Jan; 119(1):33-40. PubMed ID: 11146724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK; Tonascia JA
    Arch Ophthalmol; 2003 Apr; 121(4):466-76. PubMed ID: 12695243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal detachment in cytomegalovirus retinitis: intravenous versus intravitreal therapy.
    Young S; McCluskey P; Minassian DC; Joblin P; Jones C; Coroneo MT; Lightman S
    Clin Exp Ophthalmol; 2003 Apr; 31(2):96-102. PubMed ID: 12648040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant.
    Oktavec KC; Nolan K; Brown DM; Dunn JP; Livingston AG; Thorne JE
    Am J Ophthalmol; 2012 Apr; 153(4):728-33, 733.e1-2. PubMed ID: 22265144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
    Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic argon laser coagulation for rhegmatogenous retinal detachment in AIDS patients with cytomegalovirus retinitis.
    Althaus C; Loeffler KU; Schimkat M; Hudde T; Sundmacher R
    Graefes Arch Clin Exp Ophthalmol; 1998 May; 236(5):359-64. PubMed ID: 9602320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
    Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis.
    Guembel HO; Krieglsteiner S; Rosenkranz C; Hattenbach LO; Koch FH; Ohrloff C
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):824-9. PubMed ID: 10502057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF; Garcia RA; Mendoza AJ
    Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
    Kuo IC; Kempen JH; Dunn JP; Vogelsang G; Jabs DA
    Am J Ophthalmol; 2004 Sep; 138(3):338-46. PubMed ID: 15364214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
    Kappel PJ; Charonis AC; Holland GN; Narayanan R; Kulkarni AD; Yu F; Boyer DS; Engstrom RE; Kuppermann BD;
    Ophthalmology; 2006 Apr; 113(4):683.e1-8. PubMed ID: 16581428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
    Martin BK; Ricks MO; Forman MS; Jabs DA;
    Clin Infect Dis; 2007 Apr; 44(7):1001-8. PubMed ID: 17342657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating cytomegalovirus retinitis-related retinal detachment by combining silicone oil tamponade and ganciclovir implant.
    Martidis A; Danis RP; Ciulla TA
    Ophthalmic Surg Lasers; 2002; 33(2):135-9. PubMed ID: 11942545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.
    Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
    Ophthalmology; 2004 Dec; 111(12):2232-9. PubMed ID: 15582079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of highly active antiretroviral therapy on the incidence of HIV-related cytomegalovirus retinitis and retinal detachment.
    Jalali S; Reed JB; Mizoguchi M; Flynn N; Gordon J; Morse LS
    AIDS Patient Care STDS; 2000 Jul; 14(7):343-6. PubMed ID: 10935050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
    Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravitreal injection of ganciclovir in AIDS patients with cytomegalovirus retinitis].
    Fujino Y; Nagata Y; Miyoshi M; Ono A; Oka S; Iwamoto A; Kimura S; Mochizuki M
    Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):634-40. PubMed ID: 8810241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis of retinal detachment in cytomegalovirus retinitis].
    Cochereau I; Korobelnik JF; Petit E; Matheron S; Longuet P; Hoang-Xuan T
    J Fr Ophtalmol; 1995; 18(10):603-7. PubMed ID: 8568164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy.
    Goldberg DE; Wang H; Azen SP; Freeman WR
    Br J Ophthalmol; 2003 Jul; 87(7):853-5. PubMed ID: 12812884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.